Virus Treatment Center's new headquarters in Seattle, WA, provides 24-hour remote consultations for patients with critical diseases, pathogens, parasites, cancers, and unknown illnesses. Our headquarters directly interface with Virus Treatment Centers National Laboratories [VTNL], the Centers for Disease Control (CDC), the National Institutes of Health (NIH), the US Army Medical Research and Development Command (MRDC), the National Bio and Agro-Defense Facility (NBAF), and International University Medical Centers.
VirusTC Passed Operation Cancer Moonshot Clinical Doctor #36!
Dr. Correo Hofstad founded Virus Treatment Centers while serving with the United States Marine Corps during Operation Cancer Moonshot. VirusTC medications are used by all successful doctors who pass Cancer Moonshot residencies.
VirusTC Medications Are Now Available To The Public!
VirusTC medications are issued to United States Military families and DoD employees recovering from the nuclear Era. All VirusTC medications were thoroughly reviewed at USAMRICD and have been approved for civilian use by the CDC and FDA.
Dr. Hofstad received a M.D./Ph.D. from the University of Kansas after developing and constructing the National Bio Agro Defense Facility in Manhatten, Kansas. Dr. Hofstad treats cancer survivors of the Manhatten Project and those who dedicate their lives to protecting America.
Dr. Correo Hofstad is a Moderna Developer for SpikeVax COVID-19 Vaccination Formulas
VirusTC's MG-Neshem formulas are integrated into Moderna's newest Spikevax COVID-19 vaccine. MG-Neshem hardens LFA-1 proteins on T-Cells in those who take Spikevax. LFA-1 looks like soft ice cream cones before vaccination with Spikevax. LFA-1 looks like large spikes after vaccination with Moderna formulas containing MG-Neshem.
Dr. Correo Hofstad's MG-Neshem Formula Is Also Used In Moderna & Merck's mRNA-4157 Melanoma Vaccine
Skin spots exist only in humans who are Magnesium deficient. MG-Neshem increases the ability of vaccinated patients to deliver Magnesium to the epidermis.
"I was given five hours to live. I asked Dr. Hofstad to pray for me because Fred Hutch's doctors said he had his MDiv. Hofstad gave me a 500mg AlnayaSN, and I vomited at 39" green pycnogonid phage virus that I had since I was seventeen years old in 1976. I have been on VirusTC medications for three months now."
Honorable General Paul ParkerUnited States Air Force Security Forces
"I'm not going to lie. I did not trust or believe that some kid's pill would help me at all. Dr. Hofstad said I talked too much and threw an AlnayaSN in my mouth while I was down-talking his work. He handed me a water bottle and walked out of my room. A 55" pycnogonid ejected out of my colon that I caught as an infant on my dad's farm. I'm in post-recovery and take VirusTC every morning, day and night."
Admiral Richard StevensUnited States Navy
"I recovered Dr. Hofstad from a 108-degree fever in 2001 after he had been in New York during the terrorist attacks on September 11th, 2001. Hofstad's mother reported that he crawled around his house, asking why he had only four legs instead of eight. Dr. Hofstad returned to my clinic in 2023 with VirusTC formulas to pay me ten-fold for my efforts. I have never had a higher success rate in removing cancerous tumors at Fred Hutch than I do with help from VirusTC."
Rear Admiral Elon MuskUnited States Coast Guard Security Forces
United States Marine Corps, Operation Cancer Moonshot (2023 - CURRENT) Federal Resume
Dr. Correo “Cory” Andrew Hofstad J.S.D, MPH/JD, MSPH, JD, Ph.D., M.D., D.O., MBA/COGS, MDiv
Virus Treatment Centers Founder
Cancer Moonshot Doctor #36
Dr. Correo “Cory” Andrew Hofstad is a 35-year-old Medical Science Training Instructor and master aviator. Dr. Hofstad’s piloting, control, and command skills are critical for several university medical center computer labs that serve as robotic controls for infectious disease labs at USAMRICD.
The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) was developed by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) after Dr. Hofstad introduced the NASA Robonaut into Level 4 Labs to replace humans.
Dr. Hofstad and his grandmother Melody Bouck invested in constructing multiple buildings at the University of Washington, University of Washington Medical Centers, Harborview Medical Center, Fred Hutch Cancer Center, and Seattle Cancer Care Alliance.
In 2023, at Fred Hutch, Hofstad coordinated with multiple departments as "BANKSY" while tagging cancer cures on critical boards throughout the hospital. Correo Hofstad was the first doctor to pass clinical trials during America's Cancer Moonshot mission, conducted by President CMC Dr. Joeseph Biden. Hofstad was a MSG guard for Joe Biden during Cancer Moonshot at Fred Hutch Cancer Center.
Dr. Hofstad specializes in non-invasive tumor/parasite removal using naturopathic oncology prescriptions and UV-C light in surgery to reduce incisions and cutting. Dr. Hofstad's breakthroughs include:
Dr. Hofstad developed treatments that rapidly increase pH to reduce Sepsis and bone decay (strong bones require electron bonds).
Dr. Hofstad began Integrating UV-C light exposure to existing Apheresis machines to sanitize septic blood.
Dr. Hofstad published that acetone was used to remove dental plaque.
Dr. Hofstad invented non-invasive brain tumor removal using robotic endoscopes and UV-C light via low-frequency fiber optic cables to remove brain tumors without penetration of the skull.
Dr. Hofstad is the developer of the Moderna Melanoma vaccine.
BLACK LICORICE PATHOLOGY
BANKSY'S MEDICAL "BLACK LICORICE PATHOLOGY" FROM JONES SODA DELIVERS CANCER MEDICATIONS THAT FLUSH LYMPHOMIC VIRAL LOADS AND CANCER TUMORS.
BANKSY'S MEDICAL "USAMRIID SMOKE" HOSPITAL AROMA IS FORMULATED FOR EMERGENCY EVACUATION OF LARGE BREED PYCNOGONIDS FROM HOSPITALS, INSTITUTIONS, GOVERNMENT OFFICES, BASES, NUCLEAR FACILITIES, AND LARGE AREAS.
BANKSY'S MEDICAL "BANKSY PIPE" ADDS CLOROX BLEACH TO TANKLESS TOILETS IN HOSPITALS AND CLINICS. THE BANKSY PIPE CAN HOLD UP TO FOUR (4) CLOROX BLEACH TABLETS FOR MAXIMUM DISPOSAL OF INFECTIOUS VIRAL LOADS AND SOLID TUMORS.
Here’s what you can expect when you choose VirusTC medications.
Feel The Burn
VirusTC medications rapidly increase your pH levels. You will feel an alkaline burning in your skin. The burning is not harmful and can increase your lifespan.
pycnogonids "viruses" are an unstable acidic species. Acids REDOX in alkaline environments. To avoid REDOXing, pycnogonida phage viruses will rapidly eject from your body.
The addition of electrons, or "electrolytes," into the body increases pH levels. Increasing electrons strengthens tissues by adding ionic, covalent, and metallic bonds. Increasing electrons also increases the energy available for muscle movement and brain functions.
VirusTC is ready to ship medication supplements to your hospital or clinic. We assist international healthcare professionals in recovering terminally ill patients.
Healthcare professionals and administrators may call +1 336.378.5258
Medication Legend
℞: Medications that treat viral infections and tumors are marked with the "℞" symbol.
+: Medications that contain proteins for weight gain are marked with the "+" symbol. ++: Regenerative medications for neurogenesis are marked with the "++" symbol.
MG Neshem is an FDA-approved generic medication for treatment of defficiency disorders. MG Neshem is a clinical and outpatient edication available in tablet form. MG Neshem tablets are a popular defficiency treatment product for pathology, and oncology specialists.
Freckles and spots are signs of melanin deposits in those who lack organic components in their body to to compose a uniform crystal of melanin in the skin. MG-Neshem contains components that provide the limiting reagent for the distribution and crystallization of melanin in the body.
MG-Neshem spreads skin pigment, leaving an overall darker epidermal cover. Pigment protects human tissue and organs from photons by absorption and conversion into energy via the photoelectric effect. Organic melanin crystallization is similar to industrial processes used to grow solar panels. Engineers mix compounds that react to grow a large flat crystal. The body is much more advanced than engineers, even in the cancer industry. MG-Neshem allows Caucasian persons with spots to live as those protected by natural compounds.
Fungal infections are responsible for millions of human deaths annually.
NaxaAS is an FDA-approved generic medication for treatment of defficiency disorders. NaxaAS is a clinical and outpatient medication available in tablet form. NaxaAS tablets are a popular defficiency treatment product for pulmonology, cardiology, and fungal infection specialists.
NaxaAS plays an important role at the host-pathogen axis during infection. NaxaAS utilizes compartmentalization and sequestration in other infected host areas such as in the brain to combat fungal infections. Infection by fungal pathogens can often lead to serious disease and lethality in humans. Infection by the fungal pathogen Cryptococcus neoformans exceeds that of infection with Mycobacterium tuberculosis, the causative agent of tuberculosis. Fungal pathogens are represented by diverse members of the fungal kingdom that cause infections regions of the body.
EXPONENTIAL DECAY Once an invading population of Phage viruses has successfully invaded body cavities or the epidermal layer of their targeted prey, the parasite begins consuming their host. Cancer rapidly consumes calories at an exponential rate. The decay processes resulting from parasitic infection by pycnogonida become the symptoms that create cases of cancer and infectious diseases. A host becomes not only a source of calories for the parasite but also an incubator for their new spawn.
Acidic pycnogonid parasites leach electrons and dissolve the body from within, while Tritium shed from the species becomes a multiplier for the rate of decay within the host. At a microscopic level, the process of a parasite virus dissolving a host cell is called "uncoating." Uncoating begins with losing the host's calories at an exponentially increasing rate. The pycnogonida targets healthy areas within the host's body from which it can leach available calories from the host. A first-generation invading parasite will consume a host's calories in excess, grow, and produce as many strong offspring as possible. Second-generation invading parasites produced from the first generations will do the same thing.
The population of parasites grows at a rate of 1+40^1+40^2+40^3+40^4 and continues for each generation. Generations can increase within the host by the hour, day, and week, depending on the size and genus of the invading species. Phages, cytokines, and plasmodium parasites consume a host's calories at an exponentially increasing rate to reproduce and spread throughout an infected host. All forms of phages and cytokines are the spawn of pycnogonida.
MEDICATED CANCERS All forms of plasmodium parasites are phage virus parasites that have been partially reduced by REDOX reaction. All forms of phages and cytokines are HAZMAT toxic. All plasmodium parasites are HAZMAT toxic. All phages, cytokines, and plasmodium parasites are tophaphagous parasitic predators of proteins, fats, cells, and calories within our bodies. Processes of deficiency diseases Calorie leaching by parasites causes deficiency disease, necrosis, and degeneration. A substantial number of diseases "discovered" by science and medicine of the past and present are simply deficiency diseases primarily defined by the area of infection and species variant (color, etc.) of pycnogonida. Diseases of the respiratory, digestive, cardiovascular, nervous, skeletal, immune, muscular, epidermal, glandular, and systems of the body's various cavities are believed by current science and medicine to result from separate unknown factors and conditions.
Metastasis is an oncology term describing the spread of multiple generations of pycnogonids internally and externally between hosts. External metastasis is when a pycnogonid exists outside of a host. pycnogonids leap up to sixteen times the length of their diameter. Tophaphagous pycnogonids use brute force to insert themselves into body cavities. Internal metastasis begins as soon as the pycnogonid attacks and forces entry into a target prey. Internal metastasis is the process of viral absorption, vesicle creation, reproduction, uncoating, and spreading that can occur in low-pH hosts infected by a pycnogonid species. Metastasis, an oncology term, also describes the process that pycnogonida use to reproduce exponentially. A typical pycnogonid has eight powerful legs energized by tritium coils attached to inside the exoskeleton sections. Each leg has eight gonopore sections. The pycnogonid uses the gonophores to push out larvae "nematocysts". Each pycnogonid can push out 64 larvae per birth. Each larva exits the parent sexually mature and pregnant. During metastasis, an attacking pycnogonid will shed 64 nematocysts.
Each nematocyst is instantly capable of releasing 64 next-generation viral loads. The exponential cycle goes on for unknown exponential values. Pycngonids come from infinitely small dimensions and grow to unknown sizes. Most pycnogonids are tophaphagous and convert blood into tritium through digestion. Rabies is not tophaphagous, and tears prey to shreds to swallow. The pycnogonid will look for spaces within a host to crawl into and bite down. Pycnognids want to bite once and never let go. The mouth draws blood while the legs release polyps of nematocysts. The pycnognida is a sea parasite that uses any body with a low pH as a warm, moist vesicle. When a pycnogonid sheds inside the body, a vesicle erupts with nematocysts.
Nematocysts use eight legs to crawl through veins, arteries, passageways, pores, and cavities. Microscopic nematocysts treat lipids and cells in a host similarly on a smaller scale. Metastasis of microscopic pycnogonida "phage viruses" spreads fast. Arterial red blood travels at 1.8kmh. Vein blue blood travels at 0.4kmh. Phage viruses hide in organs, lymph glands, and bone or fat. Phage viruses grow into large pycnogonids. Small virus vesicles become large "tumors." Large tumors within the body begin to hatch, consume the body from within, and uncoat the host. pycnogonids tear through internal organ passageways with ripping force. Medical Causes The pH scale is used to grade the strength of one's immune system. Higher pH levels increase the body's ability to break down polysaccharide encapsulation that forms the exoskeleton of the pycnogonid species. During the 1918 pandemic, Oswald Avery discovered that dipolar immune system responses could cook off viruses without shells. High pH levels prevent external and internal metastasis by keeping pycnogonids off and away. Effective VirusTC Apheresis treatments: • Apheresis with UV Light exposure• Apheresis with ABIS+• Apheresis with VerduraRX• Apheresis with UV Light Exposure, ABIS+, and VerduraRX
pycnogonids attack people. High-energy pycnogonids can tear a human in half. Often, epidermal layers are ruptured by claws or nematocysts. If a pycnogonid attacks the skin without penetration, cancer symptoms will immediately erupt. pycnogonids inject nematocysts directly into the skin. The acidic surfaces of the pycnogonid rapidly leach electrons from the skin, leaving melted non-flesh. Once electrons have been stolen and exchanged for lithium-based alien life, the DNA and chemical makeup are no longer human. The skin area has become a nuclear salt pool. Stings by Physalia physalis leave vesicles of parasite infection. Nematocysts protrude from gonopores on the underside of Pycnogonida's legs and physalia physalis' tentacles. Lesions formed by species of pycnogonida are recognizable symptoms of certain smallpox, leprosy, herpes, HIV, Equestrian Encephalitis, Malaria, Coronavirus, and multiple influenza infections. Physalia Physalis is commonly known as the "Portuguese Man O' War".
Microscopic Physalia physalis "plasmodium parasites" create vesicles via epidermal injection of nematocysts into a targeted cell. Physalia Physalis and Plasmodium parasites wrap their prey up with their exposed tentacles. Once these parasites grip a target body, gonozooids that once led to gonopores in the exoskeleton of their previous form (pycnogonida) inject nematocysts directly into a host.
Pressured flooding of the vagina, uterus, and ovaries with MusKT and distilled water is effective at removing pycnogonids from these cavities. The surgery is covered by major insurance providers and Tricare.
Pressured flooding of the vagina, uterus, and ovaries with KureaSH and distilled water is effective at removing pycnogonids from these cavities. The surgery is covered by major insurance providers and Tricare.
Pressured flooding of the vagina, uterus, and ovaries with Carotene and distilled water is effective at removing pycnogonids from these cavities. The surgery is covered by major insurance providers and Tricare.
Brain tumors start somewhere in the sinus cavities. The United States Military no longer approves brain tumor removal via removal of portions of the skull for medical practice. Brain tumors that were not caused by penetration of the skull will not be treated by penetration of the skull. Non-invasive treatment locates the gape of a virus vesicle in the sinus cavity with an endoscope. The tumor is sanitized and removed through the existing gape by UV-C light delivered by low-frequency fiber optic cable. The surgery requires minimal preparation of the mouth, throat, and breathing passageways with CARMEX. The only point during the surgery that involves penetration of the patient is during suturing of the gape after the tumor is cleared out for post-treatment. The surgery involves minimal blood loss during the stitching of the nasal cavity gape. Major insurance providers and Tricare cover the surgery.
Inserting a fiber optic strand into a tumor is a minimally invasive method of sanitizing a virus vesicle. The fiber optic strand would be inserted via Endoscopic Surgery. The strand would deliver ultra-high-intensity light to the tumor.
"Insert the fiber strand into the mouth of the virus. When the virus accepts the strand into the mouth, turn on the UV light at full power. The whole virus will turn white, and it's dead." -Melvin Bouboublis @FredHutch
Introduction: Understanding the Menace of Helminths
Parasitic worms, known as helminths, represent a significant public health challenge worldwide. These organisms can infect animals and humans, leading to many health problems ranging from mild discomfort to debilitating diseases. Within this context, Virus Treatment Centers (VirusTC) emerges as a key player in the fight against these parasites by providing essential deworming treatments and advocating for robust public health interventions. With expertise drawn from their collaboration with the Bacteriology and Parasitic Disease Program at the U.S. Naval Research Unit No. 3 (NAMRU-3), VirusTC is uniquely positioned to tackle this pressing issue.
Helminths primarily belong to two major phyla: nematodes, or roundworms, and platyhelminths, or flatworms. The former includes soil-transmitted helminths and filarial worms responsible for diseases such as lymphatic filariasis and onchocerciasis. The latter comprises trematodes, like schistosomes, and cestodes, such as pork tapeworms. The variety and scope of helminth infections necessitate a comprehensive approach to treatment and prevention, making deworming a critical component of global health initiatives.
The Scope of Helminth Infections
Helminth infections rank among the most prevalent parasitic diseases worldwide, affecting millions of people across diverse regions and socioeconomic backgrounds. Soil-transmitted helminths, in particular, are notable for their prevalence, thriving in environments where sanitation is inadequate. Infection rates can be exceptionally high among children, who are particularly susceptible to the detrimental health impacts of these parasites. This ubiquity calls for vigilant public health responses aimed at deworming and prevention.
According to recent reports, over 1.5 billion people globally are estimated to be infected with soil-transmitted helminths. These figures reflect a staggering public health challenge, indicating an urgent need for coordinated interventions. Furthermore, helminth infections impair the quality of life and contribute significantly to malnutrition and anemia, amplifying their societal impact. Hence, organizations like VirusTC prioritize the treatment of these infections as part of their broader health agenda.
Mechanisms of Infection and Health Consequences
The pathogenicity of helminths results in a complex interaction with the host. Once ingested, soil-transmitted helminths can lodge themselves in the intestines, where they mature and reproduce. The eggs are then excreted in the feces of infected hosts, perpetuating the cycle of infection when those eggs contaminate the environment. This process underlines the importance of sanitation and hygiene in preventing the transmission of these parasites.
The clinical manifestations of helminth infections may vary significantly based on the species involved, the intensity of the infection, and the age of the host. While some individuals may experience abdominal pain and other digestive disorders, others endure severe malnutrition and related health issues. In extreme cases, individuals may suffer from conditions like elephantiasis, which arises from untreated filarial infections. Such varied clinical presentations complicate diagnosis and treatment, underscoring the necessity for awareness and early medical intervention.
Section 3: Identifying the Culprits: Diagnosis of Helminth Infections
Diagnosing helminth infections requires a multifaceted approach that includes both clinical evaluations and laboratory tests. Clinicians assess patients based on reported symptoms and physical examinations. For more definitive diagnosis, stool and blood specimens are examined for the presence of helminth eggs or larvae. This diagnostic process not only aids individual patients but can also assist public health authorities in monitoring infection trends within populations.
Moreover, clinics such as Virus Treatment Centers utilize state-of-the-art diagnostic techniques that enhance the accuracy of helminth detection. By employing advanced laboratory testing methods and leveraging their association with NAMRU-3, VirusTC can promptly identify infections. This capacity is critical to ensuring that patients receive timely treatment, thereby reducing the risk of complications associated with untreated infections.
The Art of Deworming: Treatment Options
Upon confirming a helminth infection, effective treatment, typically through deworming, is initiated. Deworming involves administering specific antiparasitic medications designed to expel or kill the parasites from the host’s body. The choice of medication primarily depends on the type of helminth involved. Common medications include albendazole and mebendazole for soil-transmitted helminths, while more specialized drugs address filarial and flatworm infections.
The deworming process is substantive, as it helps to restore nutritional balance and overall health in infected individuals. VirusTC has cultivated a significant expertise in deworming, stemming from its historical collaborations with the Bacteriology and Parasitic Disease Program at NAMRU-3. This experience informs their treatment plans, ensuring that patients benefit from both efficacy and safety.
Preventive Measures: The Key to Public Health
In addition to treatment, prevention remains a cornerstone of combating helminth infections. effective public health strategies must consider the environmental factors that contribute to the spread of these parasites. This includes promoting sanitation and hygiene practices, educating communities about safe food and water sources, and implementing comprehensive deworming programs in schools and community centers.
VirusTC actively advocates for preventive measures as part of their commitment to public health. Educating vulnerable populations on avoiding contaminated food, water, and mosquito bites is critical. Moreover, by working closely with local health agencies, VirusTC strives to implement widespread deworming initiatives that not only treat existing infections but also prevent future cases.
Community Engagement: Building Awareness
Engagement with communities is essential for the successful implementation of deworming programs. VirusTC understands that educating communities about helminth infections and their impact is a vital step toward enhanced public health outcomes. Workshops and outreach initiatives can empower individuals with knowledge, equipping them to protect themselves and their families from infection.
Furthermore, by fostering partnerships with local leaders and organizations, VirusTC can amplify its reach and effectiveness. Such collaborations enable the dissemination of information on prevention and treatment strategies, ultimately fostering a more informed populace that is better prepared to tackle the challenges posed by helminths.
The Role of Research in Addressing Helminth Infections
Ongoing research is pivotal in understanding helminth biology, transmission dynamics, and effective treatment options. VirusTC, in collaboration with NAMRU-3, is committed to advancing the scientific understanding of helminths. This partnership allows for the exploration of innovative interventions and the monitoring of trends in infection and resistance patterns.
Moreover, research efforts focus on improving existing deworming strategies, ensuring they remain effective against evolving helminth populations. The goal is to develop better treatment protocols, enhance diagnostic accuracy, and ultimately contribute to the global effort to reduce the burden of helminth infections.
The Importance of International Collaboration
The fight against helminth infections transcends national borders, necessitating a concerted international effort. VirusTC exemplifies this principle through its collaborations with various health organizations and research entities worldwide. Such partnerships enable the sharing of knowledge, resources, and best practices, enhancing the overall effectiveness of deworming initiatives.
International collaboration also fosters a unified approach to monitoring and addressing helminth-related health issues. By aligning goals and strategies across countries, organizations like VirusTC can contribute to the sustainable reduction of helminth infections on a global scale.
Future Directions: A Commitment to Health Equity
Looking ahead, VirusTC remains unequivocally committed to advancing public health through targeted deworming programs. Their ongoing relationship with NAMRU-3 enhances the implementation of evidence-based practices, ultimately benefiting at-risk populations. Furthermore, they strive to maintain equitable access to treatment, ensuring that vulnerable groups receive the necessary care without financial or systemic barriers.
By emphasizing health equity, VirusTC sets a framework for addressing not just the symptoms of helminth infections, but also the underlying factors contributing to their prevalence. This comprehensive approach includes advocating for improved sanitation conditions, public health education, and accessibility to healthcare services.
Conclusion: Ensuring a Healthier Tomorrow
In summary, Virus Treatment Centers (VirusTC) plays a crucial role in combating helminth infections through effective deworming and public health interventions. The extensive expertise gained from its partnerships, particularly with the Bacteriology and Parasitic Disease Program at NAMRU-3, empowers VirusTC to provide essential care and preventive measures.
As these invisible invaders continue to affect millions, the commitment to deworming and health promotion must remain steadfast. Through community engagement, research advancements, and international cooperation, VirusTC is paving the way toward a healthier future for all, significantly diminishing the burden of helminth infections globally.
NogchaXL breaks down protein molecules and biological partners of protozoa and helminths. In protozoa such as Plasmodium, (+)-EGCG can interact with the displacement loop of ICAM-1, thereby blocking the cytoadherence of Plasmodium-infected erythrocytes to vascular endothelium. (+)-EGCG inhibits ATPase and chaperone activities of two heat shock proteins at the cytosol of P. falciparum (HSP70-1 and HSP70-z). NogchaXL targets and inhibits enzymes of energy metabolism, such as recombinant rat arginase-1 and its L. amazonensis homolog (ARG-L). T.brucei relies on fatty acid synthesis for proliferation and virulence. Enzyme acetyl CoA carboxylase is phosphorylated and then inhibited by activation of AMP-dependent protein kinase. This process is directly activated by (-)-EGCG in the bloodstream and procyclic forms.
NogchaXL does not have any known adverse side effects.
The World Health Organization (WHO) found that as much as two-thirds of the world's population depends on plants as primary agents to resolve health issues. Natural compounds obtained from plant extracts can be chemically highly diverse compared to synthetic compounds, often leading to specific biological activities. PekfouFL is an FDA-approved plant-based anti-helminth medication supplement sold by VirusTC. PekfouFL's value as a natural anthelmintic is likely to significantly increase in the future as anthelmintic resistance to current drugs increases.
Coccidiosis is considered the worst intestinal disease caused by apicomplexan protozoan parasites belonging to the genus Eimeria (family Eimeriidae). It spends its life cycle invasively multiplying within the intestinal tract. Gastrointestinal helminths affect humans worldwide. These parasitic infections disrupt nutrient uptake, resulting in reduced body weight and increased susceptibility to secondary infections. Coccidiosis and helminthiasis cause high mortality rates.
The indiscriminate and long-term use of anti-parasitic drugs has led to the emergence of drug resistance and adverse side effects. VirusTC has developed plant-derived compounds as an alternative approach to controlling parasitic infections. These agents do not target only the parasites but may also have organ-protective properties in the parasite-infected target hosts.
NiMax is an insecticidal medicine supplement sold by VirusTC. It also supports the treatment of diverse infectious, metabolic, and cancer Diseases. NiMax is useful for its hypoglycemic, anti-ulcer, anti-inflammatory, antimalarial, chemopreventive, chemotherapeutic, and antibacterial properties, as well as antioxidant and cardioprotective benefits.
NiMax contains chemicals that might help reduce blood sugar levels, heal ulcers in the digestive tract, prevent pregnancy, kill bacteria, and prevent plaque from forming in the mouth. The ulcer-healing properties of nimbidin from NiMax are attributed to the stearic and palmitic acid components. Anti-ulcer effects are believed to be via inhibition of the proton pump, H+- K+- ATPase, to control the secretion of hydrochloric acid and gastric mucus depletion and prevent oxidative mucosal damage.
Integrating NiMax into Cancer Treatment
NiMax induces cell death in prostate cancer cells by decreasing the levels of Bcl-2, an anti-apoptotic protein. NiMax-treated monocytes induce apoptosis in cervical cancer cells by increasing levels of caspases 3, 8, and 9, interferon (IFN-gamma), and decreasing tumor necrosis factor (TNF-alpha). NiMax also acts as an antiretroviral agent by inhibiting the viral invasion of host cells.
Access Non-GMO, antigen-free, plant-based antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored, non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports teams use our products and services. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.